The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
Title: | The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation |
---|---|
Authors: | Knoll, Rainer, Helbig, Elisa T., Dahm, Kilian, Bolaji, Olufemi, Hamm, Frederik, Dietrich, Oliver, van Uelft, Martina, Müller, Sophie, Bonaguro, Lorenzo, Schulte-Schrepping, Jonas, Petrov, Lev, Krämer, Benjamin, Kraut, Michael, Stubbemann, Paula, Thibeault, Charlotte, Brumhard, Sophia, Theis, Heidi, Hack, Gudrun, De Domenico, Elena, Nattermann, Jacob, Becker, Matthias, Beyer, Marc D., Hillus, David, Georg, Philipp, Loers, Constantin, Tiedemann, Janina, Tober-Lau, Pinkus, Lippert, Lena, Millet Pascual-Leone, Belén, Tacke, Frank, Rohde, Gernot, Suttorp, Norbert, Witzenrath, Martin, Saliba, Antoine-Emmanuel, Ulas, Thomas, Polansky, Julia K., Sawitzki, Birgit, Sander, Leif E., Schultze, Joachim L., Aschenbrenner, Anna C., Kurth, Florian |
Source: | In Cell 8 August 2024 187(16):4318-4335 |
Database: | ScienceDirect |
Be the first to leave a comment!